Table 1.
Baseline characteristics for the 14 healthy subjects participating in the 4 week intervention1
| Treatment | ||
|---|---|---|
| Control group (n = 5) |
Phytanic acid group (n = 9) |
|
| Women, n | 2 | 6 |
| Age, y | 31.6 ± 10.3 (20-42) | 28.3 ± 5.2 (21-36) |
| Height, cm | 174.6 ± 12.8 (158-190) | 171.5 ± 6.9 (162.5-181.5) |
| Weight, kg | 68.7 ± 10.9 (56.1-80.25) | 65.5 ± 9.5 (54.20-82.95) |
| BMI, kg/m2 | 22.4 ± 1.7 (20.36-24.5) | 22.2 ± 2.1 (19.7-26.2) |
| Phytanic acid, μM | 3.35 ± 1.49 (1.75-5.41) | 2.93 ± 0.85 (1.89-4.12) |
| Glucose, mmol/L | 5.53 ± 0.6 (5.11-6.58) | 5.29 ± 0.33 (4.81-5.88) |
| Insulin, pmol/L | 22.68 ± 11.88 (7.2-39.1) | 29.86 ± 24.58 (7.2-86.6) |
| TAG, mmol/L | 0.76 ± 0.35 (0.44-1.31) | 0.88 ± 0.22 (0.63-1.32) |
| Total CH, mmol/L | 4.22 ± 1.01 (3.14-5.38) | 4.23 ± 0.83 (2.92-5.87) |
| LDL CH, mmol/L | 2.39 ± 0.72 (1.67-3.24) | 2.35 ± 0.54 (1.7-3.55) |
| HDL CH, mmol/L | 1.41 ± 0.3 (1.04-1.83) | 1.47 ± 0.3 (0.91-1.91) |
| CRP, mg/L | 0.54 ± 0.96 (0,05-2.26) | 1.25 ± 0.86 (0.05-2.62) |
1Values are mean ± SD; range in parentheses. CPR, C-reactive protein; CH, Cholesterol; TAG, Triacylglycerol. There were no significant differences between baseline values in the 2 groups (ANCOVA).